tiprankstipranks
Trending News
More News >
Changmao Biochemical Engineering Co. Ltd. Class H (HK:0954)
:0954

Changmao Biochemical Engineering Co. Ltd. Class H (0954) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Changmao Biochemical Engineering Co. Ltd. Class H has a market cap or net worth of €148.32M. The enterprise value is ―.
Market Cap€148.32M
Enterprise Value

Share Statistics

Changmao Biochemical Engineering Co. Ltd. Class H has 183,700,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding183,700,000
Owned by Insiders
Owned by Institutions

Financial Efficiency

Changmao Biochemical Engineering Co. Ltd. Class H’s return on equity (ROE) is -0.12 and return on invested capital (ROIC) is -4.97%.
Return on Equity (ROE)-0.12
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-4.97%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee1.02M
Profits Per Employee-119.51K
Employee Count571
Asset Turnover0.47
Inventory Turnover3.96

Valuation Ratios

The current PE Ratio of Changmao Biochemical Engineering Co. Ltd. Class H is -2.92. Changmao Biochemical Engineering Co. Ltd. Class H’s PEG ratio is -0.05.
PE Ratio-2.92
PS Ratio0.00
PB Ratio0.24
Price to Fair Value0.34
Price to FCF-1.72
Price to Operating Cash Flow-5.37
PEG Ratio-0.05

Income Statement

In the last 12 months, Changmao Biochemical Engineering Co. Ltd. Class H had revenue of 584.79M and earned -68.24M in profits. Earnings per share was -0.13.
Revenue584.79M
Gross Profit16.78M
Operating Income-57.07M
Pretax Income-67.58M
Net Income-68.24M
EBITDA-17.71M
Earnings Per Share (EPS)-0.13

Cash Flow

In the last 12 months, operating cash flow was -26.59M and capital expenditures -53.41M, giving a free cash flow of -80.00M billion.
Operating Cash Flow-26.59M
Free Cash Flow-80.00M
Free Cash Flow per Share-0.44

Dividends & Yields

Changmao Biochemical Engineering Co. Ltd. Class H pays an annual dividend of HK$0.086, resulting in a dividend yield of ―
Dividend Per ShareHK$0.086
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.14
52-Week Price Change-38.89%
50-Day Moving Average0.32
200-Day Moving Average0.39
Relative Strength Index (RSI)37.90
Average Volume (3m)499.33K

Important Dates

Changmao Biochemical Engineering Co. Ltd. Class H upcoming earnings date is Aug 15, 2025, TBA Not Confirmed.
Last Earnings DateMar 28, 2025
Next Earnings DateAug 15, 2025
Ex-Dividend DateMay 22, 2023

Financial Position

Changmao Biochemical Engineering Co. Ltd. Class H as a current ratio of 0.49, with Debt / Equity ratio of 91.89%
Current Ratio0.49
Quick Ratio0.26
Debt to Market Cap2.69
Net Debt to EBITDA-27.00
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Changmao Biochemical Engineering Co. Ltd. Class H has paid 669.00K in taxes.
Income Tax669.00K
Effective Tax Rate>-0.01

Enterprise Valuation

Changmao Biochemical Engineering Co. Ltd. Class H EV to EBITDA ratio is -38.24, with an EV/FCF ratio of 0.00.
EV to Sales1.16
EV to EBITDA-38.24
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00

Balance Sheet

Changmao Biochemical Engineering Co. Ltd. Class H has €74.56M in cash and marketable securities with ¥536.13M in debt, giving a net cash position of €461.57M billion.
Cash & Marketable Securities€74.56M
Total Debt¥536.13M
Net Cash€461.57M
Net Cash Per Share€2.51
Tangible Book Value Per Share€1.10

Margins

Gross margin is 2.87%, with operating margin of -9.76%, and net profit margin of -11.67%.
Gross Margin2.87%
Operating Margin-9.76%
Pretax Margin-11.56%
Net Profit Margin-11.67%
EBITDA Margin-3.03%
EBIT Margin-9.81%

Analyst Forecast

The average price target for Changmao Biochemical Engineering Co. Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-9.85%
EPS Growth Forecast20.22%

Scores

Smart ScoreN/A
AI Score38
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis